BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1742724)

  • 1. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
    Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
    Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
    Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
    Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear matrix proteins as biomarkers in prostate cancer.
    Leman ES; Getzenberg RH
    J Cell Biochem; 2002; 86(2):213-23. PubMed ID: 12111991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common set of nuclear matrix proteins in prostate cancer cells.
    Pienta KJ; Lehr JE
    Prostate; 1993; 23(1):61-7. PubMed ID: 8337186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
    Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
    J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer-associated nuclear matrix proteins.
    Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
    Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of nuclear lamins in normal and cancerous prostate tissues.
    Coradeghini R; Barboro P; Rubagotti A; Boccardo F; Parodi S; Carmignani G; D'Arrigo C; Patrone E; Balbi C
    Oncol Rep; 2006 Mar; 15(3):609-13. PubMed ID: 16465420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.
    Barboro P; D'Arrigo C; Repaci E; Bagnasco L; Orecchia P; Carnemolla B; Patrone E; Balbi C
    Exp Cell Res; 2009 Jan; 315(2):226-39. PubMed ID: 19000672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear matrix proteins in normal and breast cancer cells.
    Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
    Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common nuclear matrix proteins in rat tissues.
    Korosec T; Gerner C; Sauermann G
    Electrophoresis; 1997 Oct; 18(11):2109-15. PubMed ID: 9420177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
    Leman ES; Madigan MC; Brünagel G; Takaha N; Coffey DS; Getzenberg RH
    J Cell Biochem; 2003 Feb; 88(3):599-608. PubMed ID: 12532335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear matrix of human ovarian cancer cells in vitro.
    Yang L; Yam GH; Fey EG; Cheng-Chew SB; Tsao GS; Wang ZH; Chew EC
    Anticancer Res; 1998; 18(4A):2535-9. PubMed ID: 9703906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
    Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
    Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines.
    Samuel SK; Minish TM; Davie JR
    J Cell Biochem; 1997 Jul; 66(1):9-15. PubMed ID: 9215523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular distribution in vivo of testosterone and salt extractability of nuclear androgen complexes in the prostate and prostatic adenocarcinoma: effect of estrogen treatment.
    Batra S; Wännman H; Alenfall J; Forsgren B
    In Vivo; 1992; 6(6):573-8. PubMed ID: 1296804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoretic analysis of nuclear matrix proteins in human hepatocellular carcinoma.
    Chew EC; Liew CT; Wu S; Yang L; Yam HF; Wang SW; Lee SM; Wang ZH; Chew-Cheng SB
    Anticancer Res; 1997; 17(5A):3581-5. PubMed ID: 9413206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue.
    Epner DE; Coffey DS
    Prostate; 1996 Jun; 28(6):372-8. PubMed ID: 8650074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
    Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
    J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
    Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
    Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
    Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C
    J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.